Answers are grounded in this paper and cite their sources.
Min Wua, Xian Zhangb, Ruili Wua* , Guochun Wangc, Jinjie Lia, Yujuan Chaib*, Huaibin Shena & Lin Song Lia*a Key Lab for Special Functional Materials of Ministry of Education, National and Local Joint Engineering Research Center for High-Efficiency Display and Lighting Technology, School of Materials Science and Engineering, and Collaborative Innovation Center of Nano Functional Materials and Applications, Henan University, Kaifeng, China; b NepQD Biotech Corp, Shenzhen, China; c NovoQD Technologies, Fayetteville, AR, USASupplemental data for this article is available online at https://doi.org/10.1080/00032719.2020.1719125CONTACT Ruili Wu wrl0378@henu.edu.cn; Lin Song Li lsli@henu.edu.cn Key Lab for Special Functional Materials of Ministry of Education, National and Local Joint Engineering Research Center for High-Efficiency Display and Lighting Technology, School of Materials Science and Engineering, and Collaborative Innovation Center of Nano Functional Materials and Applications, Henan University, Kaifeng 475004, China; Yujuan Chai c-sai@nepqd.com NepQD Biotech Corp, Shenzhen 518000, China.AbstractCardiac troponin I is generally used as a biomarker of myocardial infarction or acute myocardial infarction. A timely and rapid diagnosis method for cardiac troponin I is of great importance. In this paper, a novel CdSe/ZnS quantum dot (QD) based fluorescence lateral flow immunoassay (QD-LFIA) is reported for the rapid and quantitative detection of cardiac troponin I in human serum. The water-soluble silica-encapsulated QDs (QDs@SiO2) serve as a new fluorescent probe and an economical, portable, quantitative instrument was used for the first time to detect cardiac troponin I antigen. By using the optimized immunoassay procedure with clinical samples, cardiac troponin I was determined in 10 min with high sensitivity (as low as 5.6 × 10−3 ng/mL), broad linear range (0.8–200 ng/mL), and good precision (the coefficient of variation was less than 10%). The comparison of this new QD-LFIA and a standard direct chemiluminescence assay demonstrated that the former platform was rapid, low-cost, and sensitive. It may be further applied to the quantitative determination and monitoring of cardiac troponin I levels in clinical use.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: